List of Contents

Drug Discovery Market Size, Share, and Trends 2024 to 2034

The global drug discoverymarket size is estimated at USD 65.84 billion in 2024, grew to USD 71.89 billion in 2025 and is predicted to surpass around USD 158.74 billion by 2034, expanding at a CAGR of 9.20% between 2024 and 2034.

  • Last Updated : October 2024
  • Report Code : 1464
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Drug Discovery Market 

5.1. COVID-19 Landscape: Drug Discovery Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Drug Discovery Market, By End User

8.1. Drug Discovery Market, by End User Type, 2024-2034

8.1.1. Pharmaceutical Companies

8.1.1.1. Market Revenue and Forecast (2021-2034)

8.1.2. CROs

8.1.2.1. Market Revenue and Forecast (2021-2034)

8.1.3. Others

8.1.3.1. Market Revenue and Forecast (2021-2034)

Chapter 9. Global Drug Discovery Market, By Drug Type

9.1. Drug Discovery Market, by Drug Type, 2024-2034

9.1.1. Small Molecule

9.1.1.1. Market Revenue and Forecast (2021-2034)

9.1.2. Large Molecule

9.1.2.1. Market Revenue and Forecast (2021-2034)

Chapter 10. Global Drug Discovery Market, By Technology 

10.1. Drug Discovery Market, by Technology, 2024-2034

10.1.1. High Throughput Screening

10.1.1.1. Market Revenue and Forecast (2021-2034)

10.1.2. Pharmacogenomics

10.1.2.1. Market Revenue and Forecast (2021-2034)

10.1.3. Combinatorial Chemistry

10.1.3.1. Market Revenue and Forecast (2021-2034)

10.1.4. Nanotechnology

10.1.4.1. Market Revenue and Forecast (2021-2034)

10.1.5. Other Technologies

10.1.5.1. Market Revenue and Forecast (2021-2034)

Chapter 11. Global Drug Discovery Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by End User (2021-2034)

11.1.2. Market Revenue and Forecast, by Drug Type (2021-2034)

11.1.3. Market Revenue and Forecast, by Technology (2021-2034)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by End User (2021-2034)

11.1.4.2. Market Revenue and Forecast, by Drug Type (2021-2034)

11.1.4.3. Market Revenue and Forecast, by Technology (2021-2034)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by End User (2021-2034)

11.1.5.2. Market Revenue and Forecast, by Drug Type (2021-2034)

11.1.5.3. Market Revenue and Forecast, by Technology (2021-2034)

11.2. Europe

11.2.1. Market Revenue and Forecast, by End User (2021-2034)

11.2.2. Market Revenue and Forecast, by Drug Type (2021-2034)

11.2.3. Market Revenue and Forecast, by Technology (2021-2034)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by End User (2021-2034)

11.2.4.2. Market Revenue and Forecast, by Drug Type (2021-2034)

11.2.4.3. Market Revenue and Forecast, by Technology (2021-2034)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by End User (2021-2034)

11.2.5.2. Market Revenue and Forecast, by Drug Type (2021-2034)

11.2.5.3. Market Revenue and Forecast, by Technology (2021-2034)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by End User (2021-2034)

11.2.6.2. Market Revenue and Forecast, by Drug Type (2021-2034)

11.2.6.3. Market Revenue and Forecast, by Technology (2021-2034)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by End User (2021-2034)

11.2.7.2. Market Revenue and Forecast, by Drug Type (2021-2034)

11.2.7.3. Market Revenue and Forecast, by Technology (2021-2034)

11.3. APAC

11.3.1. Market Revenue and Forecast, by End User (2021-2034)

11.3.2. Market Revenue and Forecast, by Drug Type (2021-2034)

11.3.3. Market Revenue and Forecast, by Technology (2021-2034)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by End User (2021-2034)

11.3.4.2. Market Revenue and Forecast, by Drug Type (2021-2034)

11.3.4.3. Market Revenue and Forecast, by Technology (2021-2034)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by End User (2021-2034)

11.3.5.2. Market Revenue and Forecast, by Drug Type (2021-2034)

11.3.5.3. Market Revenue and Forecast, by Technology (2021-2034)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by End User (2021-2034)

11.3.6.2. Market Revenue and Forecast, by Drug Type (2021-2034)

11.3.6.3. Market Revenue and Forecast, by Technology (2021-2034)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by End User (2021-2034)

11.3.7.2. Market Revenue and Forecast, by Drug Type (2021-2034)

11.3.7.3. Market Revenue and Forecast, by Technology (2021-2034)

11.4. MEA

11.4.1. Market Revenue and Forecast, by End User (2021-2034)

11.4.2. Market Revenue and Forecast, by Drug Type (2021-2034)

11.4.3. Market Revenue and Forecast, by Technology (2021-2034)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by End User (2021-2034)

11.4.4.2. Market Revenue and Forecast, by Drug Type (2021-2034)

11.4.4.3. Market Revenue and Forecast, by Technology (2021-2034)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by End User (2021-2034)

11.4.5.2. Market Revenue and Forecast, by Drug Type (2021-2034)

11.4.5.3. Market Revenue and Forecast, by Technology (2021-2034)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by End User (2021-2034)

11.4.6.2. Market Revenue and Forecast, by Drug Type (2021-2034)

11.4.6.3. Market Revenue and Forecast, by Technology (2021-2034)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by End User (2021-2034)

11.4.7.2. Market Revenue and Forecast, by Drug Type (2021-2034)

11.4.7.3. Market Revenue and Forecast, by Technology (2021-2034)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by End User (2021-2034)

11.5.2. Market Revenue and Forecast, by Drug Type (2021-2034)

11.5.3. Market Revenue and Forecast, by Technology (2021-2034)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by End User (2021-2034)

11.5.4.2. Market Revenue and Forecast, by Drug Type (2021-2034)

11.5.4.3. Market Revenue and Forecast, by Technology (2021-2034)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by End User (2021-2034)

11.5.5.2. Market Revenue and Forecast, by Drug Type (2021-2034)

11.5.5.3. Market Revenue and Forecast, by Technology (2021-2034)

Chapter 12. Company Profiles

12.1. Pfizer Inc.

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. GlaxoSmithKline PLC

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Merck & Co. Inc.

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Agilent Technologies Inc.

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Eli Lilly and Company

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. F. Hoffmann-La Roche Ltd

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Bayer AG

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Abbott Laboratories Inc.

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. AstraZeneca PLC

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Shimadzu Corp

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client